Showing results (3001-3010 of 8,048) with videos related to
Sort By:
Pageof 805
Current Medicinal Chemistry|February 17, 2010
Homodimeric enzymes as drug targetsD Cardinale, O M H Salo-Ahen, S Ferrari, et al.Current Medicinal Chemistry|February 17, 2010
The Bcl-2 family as a rational target for the treatment of B-cell chronic lymphocytic leukaemiaN Capitani, C T BaldariCurrent Medicinal Chemistry|February 18, 2010
Epoxyeicosatrienoic acid analogs and vascular functionV Sudhahar, S Shaw, J D ImigCurrent Medicinal Chemistry|February 20, 2010
GPR55: Current knowledge and future perspectives of a purported "Type-3" cannabinoid receptorAlessio Moriconi, Ilaria Cerbara, Mauro Maccarrone, et al.Current Medicinal Chemistry|February 20, 2010
Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonistsR G PertweeCurrent Medicinal Chemistry|February 20, 2010
Role of COL4A1 in basement-membrane integrity and cerebral small-vessel disease. The COL4A1 stroke syndromeI Volonghi, A Pezzini, E Del Zotto, et al.Current Medicinal Chemistry|February 20, 2010
Coumarins: old compounds with novel promising therapeutic perspectivesM E Riveiro, N De Kimpe, A Moglioni, et al.Current Medicinal Chemistry|February 20, 2010
Primate-accelerated evolutionary genes: novel routes to drug discovery in psychiatric disordersJ-M Moalic, Y Le Strat, A-M Lepagnol-Bestel, et al.Current Medicinal Chemistry|October 20, 2009
The design and development of fesoterodine as a prodrug of 5-hydroxymethyl tolterodine (5-HMT), the active metabolite of tolterodineB Malhotra, K Gandelman, R Sachse, et al.Current Medicinal Chemistry|December 27, 2005
Quorum sensing inhibition: targeting chemical communication in gram-negative bacteriaTobias Persson, Michael Givskov, John NielsenPageof 805